Drugs@FDA document

CRESEMBA Letter · NDA 207501 SUPPL-16

Drugs@FDA document · ASTELLAS · Mar 25, 2025

Key facts

Drug name CRESEMBA
Document type Letter
Application NDA207501
Submission SUPPL-16
Company ASTELLAS
Document date Mar 25, 2025

At a glance

  • Labeling-Package Insert Document categories
  • 10–99 Documents for this application
  • 10–99 USP chapters cited in this application's documents

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents